Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
16.10
-0.29 (-1.77%)
At close: Jun 27, 2025, 4:00 PM
15.77
-0.33 (-2.05%)
After-hours: Jun 27, 2025, 7:54 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.75 billion as of June 27, 2025. Its market cap has decreased by -25.85% in one year.
Market Cap
2.75B
Enterprise Value
2.04B
1-Year Change
-25.85%
Ranking
Category
Stock Price
$16.10
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.75B, an increase of 2,112.55%. That is a compound annual growth rate of 67.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |